Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
C4 Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 105K | $334K | $3.18 | Feb 14, 2025 | Direct |
C4 Therapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 42.4K | Feb 14, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CCCC | C4 Therapeutics, Inc. | Feb 14, 2025 | 2 | $0 | 4 | Feb 18, 2025 | Chief Scientific Officer |
CCCC | C4 Therapeutics, Inc. | Oct 28, 2024 | 2 | $0 | 4 | Oct 29, 2024 | Chief Scientific Officer |
CCCC | C4 Therapeutics, Inc. | Oct 28, 2024 | 0 | $0 | 3 | Oct 29, 2024 | Chief Scientific Officer |